Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2979)
All Articles published online
|
May 21, 2008 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang YL, Pang LQ, Wu Y, Wang XY, Wang CQ, Fan Y. Significance of Bcl-xL in human colon carcinoma. World J Gastroenterol 2008; 14(19): 3069-3073 [PMID: 18494061 DOI: 10.3748/wjg.14.3069] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i19/3069.htm |
| Number | Citing Articles |
| 1 |
Anna Sadowska, Halina Car, Anna Pryczynicz, Katarzyna Guzińska-Ustymowicz, Krzysztof Wojciech Kowal, Dariusz Cepowicz, Bogusław Kędra. Expression of apoptotic proteins in human colorectal cancer and metastatic lymph nodes. Pathology - Research and Practice 2014; 210(9): 576 doi: 10.1016/j.prp.2014.04.023
|
| 2 |
Simona D’Aguanno, Donatella Del Bufalo. Inhibition of Anti-Apoptotic Bcl-2 Proteins in Preclinical and Clinical Studies: Current Overview in Cancer. Cells 2020; 9(5): 1287 doi: 10.3390/cells9051287
|
| 3 |
Indy Bui, Stavroula Baritaki, Massimo Libra, Apostolos Zaravinos, Benjamin Bonavida. Cancer Resistance Is Mediated by the Upregulation of Several Anti-Apoptotic Gene Products via the Inducible Nitric Oxide Synthase/Nitric Oxide Pathway: Therapeutic Implications. Antioxidants & Redox Signaling 2023; 39(13-15): 853 doi: 10.1089/ars.2023.0250
|
| 4 |
Viroj Wiwanitkit. Re: Prognostic significance of Bcl-xL gene expression in human colorectal cancer. Acta Histochemica 2012; 114(2): 182 doi: 10.1016/j.acthis.2011.02.010
|
| 5 |
Hong-Duck Um. Bcl-2 family proteins as regulators of cancer cell invasion and metastasis: a review focusing on mitochondrial respiration and reactive oxygen species. Oncotarget 2016; 7(5): 5193 doi: 10.18632/oncotarget.6405
|
| 6 |
Brij K. Gupta, Diane M. Maher, Mara C. Ebeling, Phillip D. Stephenson, Susan E. Puumala, Michael R. Koch, Hiroyuki Aburatani, Meena Jaggi, Subhash C. Chauhan. Functions and regulation of MUC13 mucin in colon cancer cells. Journal of Gastroenterology 2014; 49(10): 1378 doi: 10.1007/s00535-013-0885-z
|
| 7 |
Ye Shen, Jason S Eng, Flordeliza Fajardo, Lingming Liang, Cong Li, Patrick Collins, Donato Tedesco, Olivier Nolan-Stevaux. Cancer cell-intrinsic resistance to BiTE therapy is mediated by loss of CD58 costimulation and modulation of the extrinsic apoptotic pathway. Journal for ImmunoTherapy of Cancer 2022; 10(3): e004348 doi: 10.1136/jitc-2021-004348
|
| 8 |
Jinsong Yang, Ming Sun, Aiping Zhang, Chengyu Lv, Wei De, Zhaoxia Wang. Adenovirus-mediated siRNA targeting Bcl-xL inhibits proliferation, reduces invasion and enhances radiosensitivity of human colorectal cancer cells. World Journal of Surgical Oncology 2011; 9(1) doi: 10.1186/1477-7819-9-117
|
| 9 |
Liang-Che Chang, Chung-Wei Fan, Wen-Ko Tseng, Hui-Ping Chein, Tsan-Yu Hsieh, Jim-Ray Chen, Cheng-Cheng Hwang, Chung-Ching Hua. The ratio of thioredoxin/Keap1 protein level is a predictor of distant metastasis in colorectal cancer. Biomarkers in Medicine 2017; 11(12): 1103 doi: 10.2217/bmm-2017-0107
|
| 10 |
Dechen Fu, Luke Pfannenstiel, Abeba Demelash, Yee Peng Phoon, Cameron Mayell, Claudia Cabrera, Caini Liu, Junjie Zhao, Josephine Dermawan, Deepa Patil, Jennifer DeVecchio, Matthew Kalady, Andrew J. Souers, Darren C. Phillips, Xiaoxia Li, Brian Gastman. MCL1 nuclear translocation induces chemoresistance in colorectal carcinoma. Cell Death & Disease 2022; 13(1) doi: 10.1038/s41419-021-04334-y
|
| 11 |
Ruiyun Wu, Nan Shang, Meng Gui, Jian Yin, Pinglan Li. Sturgeon (Acipenser)-Derived Chondroitin Sulfate Suppresses Human Colon Cancer HCT-116 Both In Vitro and In Vivo by Inhibiting Proliferation and Inducing Apoptosis. Nutrients 2020; 12(4): 1130 doi: 10.3390/nu12041130
|
| 12 |
Yang Jin-Song, Wang Zhao-Xia, Lv Cheng-Yu, Liang Xiao-Di, Sun Ming, Guo Yuan-Yuan, De Wei. Prognostic significance of Bcl-xL gene expression in human colorectal cancer. Acta Histochemica 2011; 113(8): 810 doi: 10.1016/j.acthis.2011.01.002
|
| 13 |
Weiwei Li, Yiming Ma, Longmei He, Hongwei Li, Yi Chu, Zheng Jiang, Xinhua Zhao, Yongzhan Nie, Xishan Wang, Hongying Wang. Protease-activated receptor 2 stabilizes Bcl-xL and regulates EGFR–targeted therapy response in colorectal cancer. Cancer Letters 2021; 517: 14 doi: 10.1016/j.canlet.2021.05.040
|
| 14 |
Bruno Christian Koehler, Anna-Lena Scherr, Stephan Lorenz, Christin Elssner, Nicole Kautz, Stefan Welte, Dirk Jaeger, Toni Urbanik, Henning Schulze-Bergkamen, Andrei L. Gartel. Pan-Bcl-2 Inhibitor Obatoclax Delays Cell Cycle Progression and Blocks Migration of Colorectal Cancer Cells. PLoS ONE 2014; 9(9): e106571 doi: 10.1371/journal.pone.0106571
|
| 15 |
A. Greystoke, S. A. Mullamitha. How Many Diseases Are Colorectal Cancer?. Gastroenterology Research and Practice 2012; 2012: 1 doi: 10.1155/2012/564741
|
| 16 |
Jin‐Nyoung Ho, Ga Young Kang, Seung‐Sook Lee, Jongdoo Kim, In Hwa Bae, Sang‐Gu Hwang, Hong‐Duck Um. Bcl‐XL and STAT3 mediate malignant actions of γ‐irradiation in lung cancer cells. Cancer Science 2010; 101(6): 1417 doi: 10.1111/j.1349-7006.2010.01552.x
|
| 17 |
Seung Woo Lee, Young Yong Ahn, Yon Soo Kim, Sang Beum Kang, Soon Woo Nam, Dong Soo Lee, Hyun Yong Jeong, Jin Man Kim. The Immunohistochemical Expression of STAT3, Bcl-xL, and MMP-2 Proteins in Colon Adenoma and Adenocarcinoma. Gut and Liver 2012; 6(1): 45 doi: 10.5009/gnl.2012.6.1.45
|
| 18 |
Dae Joon Kim, Ken Kataoka, Shigetoshi Sano, Kevin Connolly, Kaoru Kiguchi, John DiGiovanni. Targeted disruption of Bcl‐xL in mouse keratinocytes inhibits both UVB‐ and chemically induced skin carcinogenesis. Molecular Carcinogenesis 2009; 48(10): 873 doi: 10.1002/mc.20527
|
| 19 |
Luís Muñoz-Bellvis, Celia Fontanillo, María González-González, Eva Garcia, Manuel Iglesias, Carmen Esteban, M L Gutierrez, M M Abad, Oscar Bengoechea, Javier De Las Rivas, Alberto Orfao, J M Sayagués. Unique genetic profile of sporadic colorectal cancer liver metastasis versus primary tumors as defined by high-density single-nucleotide polymorphism arrays. Modern Pathology 2012; 25(4): 590 doi: 10.1038/modpathol.2011.195
|
| 20 |
Anna-Lena Scherr, Georg Gdynia, Mariam Salou, Praveen Radhakrishnan, Katarina Duglova, Anette Heller, Sophia Keim, Nicole Kautz, Adam Jassowicz, Christin Elssner, You-Wen He, Dirk Jaeger, Mathias Heikenwalder, Martin Schneider, Achim Weber, Wilfried Roth, Henning Schulze-Bergkamen, Bruno Christian Koehler. Bcl-xL is an oncogenic driver in colorectal cancer. Cell Death & Disease 2016; 7(8): e2342 doi: 10.1038/cddis.2016.233
|
| 21 |
Prashanthi Ramesh, Tamsin R. M. Lannagan, Rene Jackstadt, Lidia Atencia Taboada, Nico Lansu, Pratyaksha Wirapati, Sander R. van Hooff, Danielle Dekker, Jessica Pritchard, Aleksandar B. Kirov, Sanne M. van Neerven, Sabine Tejpar, Geert J. P. L. Kops, Owen J. Sansom, Jan Paul Medema. BCL-XL is crucial for progression through the adenoma-to-carcinoma sequence of colorectal cancer. Cell Death & Differentiation 2021; 28(12): 3282 doi: 10.1038/s41418-021-00816-w
|
| 22 |
Prashanthi Ramesh, Jan Paul Medema. BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy. Apoptosis 2020; 25(5-6): 305 doi: 10.1007/s10495-020-01601-9
|
| 23 |
Haruo Nakano, Tatsuya Miyazawa, Keita Kinoshita, Yoji Yamada, Tetsuo Yoshida. Functional screening identifies a microRNA, miR‐491 that induces apoptosis by targeting Bcl‐XL in colorectal cancer cells. International Journal of Cancer 2010; 127(5): 1072 doi: 10.1002/ijc.25143
|
| 24 |
M Sarkar, V Khare, M K Ghosh. The DEAD box protein p68: a novel coactivator of Stat3 in mediating oncogenesis. Oncogene 2017; 36(22): 3080 doi: 10.1038/onc.2016.449
|
| 25 |
Xinxin Song, Seog-Young Kim, Yong J. Lee, Raffaele A Calogero. Evidence for Two Modes of Synergistic Induction of Apoptosis by Mapatumumab and Oxaliplatin in Combination with Hyperthermia in Human Colon Cancer Cells. PLoS ONE 2013; 8(8): e73654 doi: 10.1371/journal.pone.0073654
|
| 26 |
Raffaele Pezzani, Sara Vitalini, Marcello Iriti. Bioactivities of Origanum vulgare L.: an update. Phytochemistry Reviews 2017; 16(6): 1253 doi: 10.1007/s11101-017-9535-z
|
| 27 |
Anke H Sillars‐Hardebol, Beatriz Carvalho, Jeroen AM Beliën, Meike de Wit, Pien M Delis‐van Diemen, Marianne Tijssen, Mark A van de Wiel, Fredrik Pontén, Remond JA Fijneman, Gerrit A Meijer. BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain . The Journal of Pathology 2012; 226(3): 442 doi: 10.1002/path.2983
|
| 28 |
Nicolas Rosa, Femke Speelman-Rooms, Jan B. Parys, Geert Bultynck. Modulation of Ca2+ signaling by antiapoptotic Bcl-2 versus Bcl-xL: From molecular mechanisms to relevance for cancer cell survival. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(6): 188791 doi: 10.1016/j.bbcan.2022.188791
|